Indian Institute of Management Ranchi celebrated the successful conclusion of its International Conference on Happiness: Science and Practice (ICHSP), marking a milestone in the institute s commitment to advancing knowledge and fostering collaboration in the field of happiness
Get latest articles and stories on Business at LatestLY. New Delhi [India], November 4: The Organisation of Pharmaceutical Producers of India (OPPI) organized the OTC Health and Wellness Conference 2023 at PHD House, New Delhi, with the objective of promoting responsible self-care among individuals. The conference aimed to empower consumers by providing them with evidence-based information on the appropriate use and safety of over the counter (OTC) medications. This event brought together industry experts, government officials, medical professionals, and consumer groups to discuss and deliberate upon the importance of responsible self-care in India. The OPPI initiative is in line with its efforts of working towards facilitating the Government in developing the OTC & self-care framework and adopting a collaborative approach to building a responsible self-care practice in our country. Business News | OPPI Hosts OTC Health and Wellness Conference to Promote Responsible Self-care.
Emcure Pharma strengthens its board; adding Independent Directors with illustrious background indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
Mumbai: Pune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies likely to file its draft red herring prospectus (DRHP) with the market regulator SEBI next week for Rs 4,000 crore initial public offering (IPO), people aware of the matter told ET.
The IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired about 13 per cent stake in the company seven years back. While the company is looking to dilute up to a 20 per cent stake, its existing investor Bain Capital aims to exit its entire holdings of 13 per cent, said sources.